1,000+ study participants!
We launched a first-of-its-kind contraception research study in November 2022 with the aim of understanding the genetic factors associated with severe side effects on hormonal contraception. We wanted to understand why some women and people assigned female at birth experience side effects that cause them to stop their hormonal contraception altogether while others respond well to the same method.
As a small team of researchers and clinicians here at Dama, we began our study aiming (hoping!) for 500 participants across the UK to enrol. By early March 2023, we reached above 1,000 participants enrolling into our study. And more, we had participants share their stories with us.
To our study participants, thank you for participating in this study. Your participation (both your time and saliva) help advance our mission of personalising contraception and help decrease the gender health gap.
We’re beginning the exciting and complex journey of analysing the study data. Stay tuned to hear about our insights in the coming months by joining our community newsletter.